Biomarin Pharmaceutical Inc - Net Worth and Insider Trading
Biomarin Pharmaceutical Inc Net Worth
The estimated net worth of Biomarin Pharmaceutical Inc is at least $141 Million dollars as of 2024-09-20. Biomarin Pharmaceutical Inc is the 10% Owner of Catalyst Pharmaceuticals Inc and owns about 6,666,667 shares of Catalyst Pharmaceuticals Inc (CPRX) stock worth over $141 Million. Details can be seen in Biomarin Pharmaceutical Inc's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Biomarin Pharmaceutical Inc has not made any transactions after 2012-12-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Biomarin Pharmaceutical Inc
Biomarin Pharmaceutical Inc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Biomarin Pharmaceutical Inc owns 2 companies in total, including Catalyst Pharmaceuticals Inc (CPRX) , and La Jolla Pharmaceutical Co (LJPC) .
Click here to see the complete history of Biomarin Pharmaceutical Inc’s form 4 insider trades.
Insider Ownership Summary of Biomarin Pharmaceutical Inc
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CPRX | Catalyst Pharmaceuticals Inc | 2012-12-08 | 10 percent owner |
| LJPC | La Jolla Pharmaceutical Co | 2009-01-20 | 10 percent owner |
Biomarin Pharmaceutical Inc Latest Holdings Summary
Biomarin Pharmaceutical Inc currently owns a total of 1 stock. Biomarin Pharmaceutical Inc owns 6,666,667 shares of Catalyst Pharmaceuticals Inc (CPRX) as of December 8, 2012, with a value of $141 Million.
Latest Holdings of Biomarin Pharmaceutical Inc
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CPRX | Catalyst Pharmaceuticals Inc | 2012-12-08 | 6,666,667 | 21.15 | 141,000,007 |
Holding Weightings of Biomarin Pharmaceutical Inc
Biomarin Pharmaceutical Inc Form 4 Trading Tracker
According to the SEC Form 4 filings, Biomarin Pharmaceutical Inc has made a total of 0 transactions in Catalyst Pharmaceuticals Inc (CPRX) over the past 5 years. The most-recent trade in Catalyst Pharmaceuticals Inc is the acquisition of 5,000,000 shares on December 8, 2012, which cost Biomarin Pharmaceutical Inc around $4 Million.
Insider Trading History of Biomarin Pharmaceutical Inc
- 1
Biomarin Pharmaceutical Inc Trading Performance
GuruFocus tracks the stock performance after each of Biomarin Pharmaceutical Inc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Biomarin Pharmaceutical Inc is 14.29%. GuruFocus also compares Biomarin Pharmaceutical Inc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Biomarin Pharmaceutical Inc within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Biomarin Pharmaceutical Inc's insider trading performs compared to the benchmark.
Performance of Biomarin Pharmaceutical Inc
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 40.48 | | | | | |
| Relative Return to S&P 500(%) | 37.72 | | | | | |
Biomarin Pharmaceutical Inc Ownership Network
Biomarin Pharmaceutical Inc Owned Company Details
What does Catalyst Pharmaceuticals Inc do?
Who are the key executives at Catalyst Pharmaceuticals Inc?
Biomarin Pharmaceutical Inc is the 10 percent owner of Catalyst Pharmaceuticals Inc. Other key executives at Catalyst Pharmaceuticals Inc include VP Development & Management Steve Miller , Chief Commercial Officer Carmen Jeffrey Del , and Chief Medical Officer Gary Ingenito .
Catalyst Pharmaceuticals Inc (CPRX) Insider Trades Summary
Over the past 18 months, Biomarin Pharmaceutical Inc made no insider transaction in Catalyst Pharmaceuticals Inc (CPRX). Other recent insider transactions involving Catalyst Pharmaceuticals Inc (CPRX) include a net sale of 120,000 shares made by David S Tierney , a net sale of 250,000 shares made by Alicia Grande , and a net sale of 230,000 shares made by Gary Ingenito .
In summary, during the past 3 months, insiders sold 301,058 shares of Catalyst Pharmaceuticals Inc (CPRX) in total and bought 0 shares, with a net sale of 301,058 shares. During the past 18 months, 961,406 shares of Catalyst Pharmaceuticals Inc (CPRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 961,406 shares.
Catalyst Pharmaceuticals Inc (CPRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Catalyst Pharmaceuticals Inc Insider Transactions
Biomarin Pharmaceutical Inc Mailing Address
Above is the net worth, insider trading, and ownership report for Biomarin Pharmaceutical Inc. You might contact Biomarin Pharmaceutical Inc via mailing address: 105 Digital Drive, Novato Ca 94949.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
